Overview
Erin Denney-Koelsch is a Palliative Medicine provider practicing medicine in Rochester, New York.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 Elmwood Ave Ste C, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Robert Horowitz is a Palliative Medicine provider practicing medicine in Rochester, New York. Dr. Horowitz is highly rated in 2 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Opioid Induced Constipation, Chronic Pain, and Smoldering Multiple Myeloma.
Orchard Rehabilitation & Nursing Center
Charles Yates is a Palliative Medicine provider practicing medicine in Medina, New York. Dr. Yates is highly rated in 1 condition, according to our data. His clinical expertise encompasses Neurofibromatosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Relapsing Multiple Sclerosis (RMS), and Seasonal Affective Disorder (SAD).
University Of Rochester
Robert Holloway is a Palliative Medicine provider practicing medicine in Rochester, New York. His clinical expertise encompasses PEPCK 1 Deficiency, Dihydrolipoamide Dehydrogenase Deficiency, Autosomal Recessive Congenital Methemoglobinemia, and Pyruvate Carboxylase Deficiency.
Frequently Asked Questions about Dr. Erin M. Denney-Koelsch
How do I make an appointment with Dr. Erin M. Denney-Koelsch?
You can book an appointment with Dr. Erin M. Denney-Koelsch by calling their office at 585-273-1154. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Erin M. Denney-Koelsch a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Erin M. Denney-Koelsch is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Erin M. Denney-Koelsch specialize in?
While Dr. Erin M. Denney-Koelsch is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Erin M. Denney-Koelsch participate in research or clinical trials?
Yes. Dr. Erin M. Denney-Koelsch has published 14 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Erin M. Denney-Koelsch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Erin M. Denney-Koelsch accept my insurance?
Dr. Erin M. Denney-Koelsch accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 585-273-1154 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Denney-Koelsch isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.